Cover Image

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes

Human pluripotent stem cells derived cardiomyocytes (PSC-CMs) have been widely used for disease modeling, drug safety screening, and preclinical cell therapy to regenerate myocardium. Most studies have utilized PSC-CM grown in vitro for a relatively short period after differentiation. These PSC-CMs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dao-Fu Dai (Author), Maria Elena Danoviz (Author), Brian Wiczer (Author), Michael A. Laflamme (Author), Rong Tian (Author)
Format:	Book
Published:	Hindawi Limited, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy
by: Yun-Gwi Park, et al.
Published: (2022)

Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
by: Masaki Honda, et al.
Published: (2011)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
by: Michelle Vanessa Kamga Kapchoup, et al.
Published: (2023)

Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia
by: Aurore Hick, et al.
Published: (2013)

Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes
by: Daiju Yamazaki, et al.
Published: (2018)

Extracellular Recordings of Patterned Human Pluripotent Stem Cell-Derived Cardiomyocytes on Aligned Fibers
by: Junjun Li, et al.
Published: (2016)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Zhihan Zhao, et al.
Published: (2018)

Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell-Derived Cardiomyocytes
by: Simon Klimovic, et al.
Published: (2022)

Deep learning-based quality control of cultured human-induced pluripotent stem cell-derived cardiomyocytes
by: Ken Orita, et al.
Published: (2019)

Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation
by: Martta Häkli, et al.
Published: (2022)

Structural and Mechanistic Bases of Nuclear Calcium Signaling in Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
by: Sen Li, et al.
Published: (2019)

Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets
by: Hiroko Izumi-Nakaseko, et al.
Published: (2017)

Human‐induced pluripotent stem cell‐derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs
by: Jorge Gomez‐Galeno, et al.
Published: (2021)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
by: Chandra Prajapati, et al.
Published: (2018)

Virulence factors released from Porphyromonas gingivalis induce electrophysiological dysfunction in human pluripotent stem cell-derived cardiomyocytes
by: Soon Chul Heo, et al.
Published: (2022)

Ca2+-currents in human induced pluripotent stem cell-derived cardiomyocytes - effects of two different culture conditions
by: Ahmet Umur Uzun, et al.
Published: (2016)

Engineering a conduction‐consistent cardiac patch with graphene oxide modified butterfly wings and human pluripotent stem cell‐derived cardiomyocytes
by: Yao Tan, et al.
Published: (2023)

Stem cell‐derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy-In a model of human-induced pluripotent stem cell-derived cardiomyocytes
by: Alina Constantin, et al.
Published: (2022)

miR-199a Overexpression Enhances the Potency of Human Induced-Pluripotent Stem-Cell-Derived Cardiomyocytes for Myocardial Repair
by: Weihua Bian, et al.
Published: (2021)

Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs
by: Min Li, et al.
Published: (2017)

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
by: Sho Tanosaki, et al.
Published: (2021)

Generation of Retinal Organoids with Mature Rods and Cones from Urine-Derived Human Induced Pluripotent Stem Cells
by: Guilan Li, et al.
Published: (2018)

Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
by: C. Altrocchi, et al.
Published: (2023)

Prospect of Human Pluripotent Stem Cell-Derived Neural Crest Stem Cells in Clinical Application
by: Qian Zhu, et al.
Published: (2016)

Acute frataxin knockdown in induced pluripotent stem cell-derived cardiomyocytes activates a type I interferon response
by: M. Grazia Cotticelli, et al.
Published: (2023)

Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers
by: Hiroko Izumi-Nakaseko, et al.
Published: (2018)

A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Diogo Crispim Nascimento Portella, et al.
Published: (2021)

Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes
by: Anna Janz, et al.
Published: (2024)

Global RNA editing identification and characterization during human pluripotent-to-cardiomyocyte differentiation
by: Juan Chen, et al.
Published: (2021)

Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update
by: Yasunari Kanda, et al.
Published: (2018)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
by: Mengying Huang, et al.
Published: (2021)

Morphometric Analysis of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes: Determining the Maturation State of a Population by Quantifying Parameters in Individual Cells
by: Harvey Y. S. Chan, et al.
Published: (2015)

Analysis of Embryoid Bodies Derived from Human Induced Pluripotent Stem Cells as a Means to Assess Pluripotency
by: Steven D. Sheridan, et al.
Published: (2012)

Assessment of the In Vitro Cytotoxicity Effects of the Leaf Methanol Extract of <i>Crinum zeylanicum</i> on Mouse Induced Pluripotent Stem Cells and Their Cardiomyocytes Derivatives
by: Magloire Kanyou Ndjenda II, et al.
Published: (2021)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
by: Huan Lan, et al.
Published: (2020)

Pharmacological Protein Kinase C Modulators Reveal a Pro-hypertrophic Role for Novel Protein Kinase C Isoforms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Lotta Pohjolainen, et al.
Published: (2021)

Mitochondrial Abnormalities in Induced Pluripotent Stem Cells-Derived Motor Neurons from Patients with Riboflavin Transporter Deficiency
by: Fiorella Colasuonno, et al.
Published: (2020)

Derivation and Identification of Motor Neurons from Human Urine-Derived Induced Pluripotent Stem Cells
by: Huan Yi, et al.
Published: (2018)

Potential Clinical Applications for Human Pluripotent Stem Cell-Derived Blood Components
by: Erin A. Kimbrel, et al.
Published: (2011)

Mitochondrial Fusion by M1 Promotes Embryoid Body Cardiac Differentiation of Human Pluripotent Stem Cells
by: Jarmon G. Lees, et al.
Published: (2019)